Growth momentum Ottobock shows strong H1 2026 growth in Product & Components B2B with revenue up 7.7% and organic growth of 8.7%, indicating a healthy demand for prosthetics and neuro-orthotics that sales teams can target with expanded supply, upsell, and cross-sell of components, accessories, and digital solutions.

Strategic acquisitions Recent and pending acquisitions including Blatchford Norway, Matton Law, and Fesia Technology signal an active expansion in both B2B and neuro-orthotics portfolios, creating opportunities to bundle complementary products, enter new regional accounts, and pitch integrated care solutions.

Regional expansion Americas revenue declined due to foreign exchangeHeadwinds, while Germany core revenue rose 7.7%, suggesting a mixed regional dynamic. Focus sales efforts on FX-resilient markets and leverage EMEA growth momentum to drive cross-border enterprise deals and regional service contracts.

Digital and care network Ottobock drives industry digitalisation with a broad patient care network and digital tools ecosystem (Looker, HubSpot, Contentful, Azure, etc.), presenting opportunities to sell connected devices, remote monitoring, digital fitting platforms, and data-enabled service agreements.

Product innovation Product launches like Taleo Adapt and planned Fesia Technology FES additions indicate a continued focus on advanced mobility and neuro-orthotics. This opens up upsell paths to clinics and hospitals seeking cutting-edge adaptive devices and rehabilitation tech with service and training packages.